Learn how the molecule EBC-46 could advance how HIV is treated and how researchers discovered it.

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more vulnerable to diseases and infections. Once inside human cells ...

Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a microbiologist at University of Pennsylvania, US. Scott Kitchen, an expert in ...

HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body’s immune system and makes ...

A mouse study at Memorial Sloan Kettering Cancer Center has found that adding Nef, a protein from HIV, allows donor CAR T cells to avoid detection by the immune system while still attacking tumors.

This allows HIV-1 to prioritize its own needs while effectively stalling the host defense mechanisms. Thus, the virus can manipulate the host cell machinery in ways that remain robust even under ...

By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells and engineering them to recognize specific targets ...

The "Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the risk factors, comorbidities, ...

“Some of the symptoms of lymphoma include persistent fever, fatigue and swollen glands, which often lead patients to assume ...

The prime minister took the test at 10 Downing Street alongside soul singer Beverley Knight, who is a strong advocate for HIV ...